Palo Alto Investors

Palo Alto Investors as of June 30, 2017

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 38 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Clovis Oncology 14.6 $312M 3.3M 93.63
Abiomed 13.1 $280M 2.0M 143.30
United Therapeutics Corporation (UTHR) 11.3 $242M 1.9M 129.73
BioMarin Pharmaceutical (BMRN) 10.1 $217M 2.4M 90.82
Alexion Pharmaceuticals 5.9 $125M 1.0M 121.67
Insmed (INSM) 4.5 $97M 5.6M 17.16
Epizyme 4.0 $86M 5.7M 15.10
Sage Therapeutics (SAGE) 3.8 $82M 1.0M 79.64
Amicus Therapeutics (FOLD) 3.7 $80M 7.9M 10.07
Wright Medical Group Nv 3.4 $74M 2.7M 27.49
Vanda Pharmaceuticals (VNDA) 3.2 $69M 4.2M 16.30
AMAG Pharmaceuticals 2.9 $62M 3.3M 18.40
Prothena (PRTA) 2.7 $58M 1.1M 54.12
ACADIA Pharmaceuticals (ACAD) 2.1 $45M 1.6M 27.89
Celgene Corporation 1.8 $38M 295k 129.87
STAAR Surgical Company (STAA) 1.8 $38M 3.5M 10.80
Align Technology (ALGN) 1.6 $34M 223k 150.12
Karyopharm Therapeutics (KPTI) 1.5 $31M 3.5M 9.05
Momenta Pharmaceuticals 1.4 $30M 1.8M 16.90
Immunomedics 1.2 $27M 3.0M 8.83
Aimmune Therapeutics 1.2 $27M 1.3M 20.56
Gilead Sciences (GILD) 1.2 $25M 352k 70.78
Shire 1.0 $22M 130k 165.27
EXACT Sciences Corporation (EXAS) 0.7 $15M 433k 35.37
Rigel Pharmaceuticals (RIGL) 0.5 $11M 3.9M 2.73
Alimera Sciences 0.2 $4.2M 3.0M 1.39
Sunesis Pharmaceuticals Inc Ne 0.1 $3.1M 1.2M 2.70
Acelrx Pharmaceuticals 0.1 $2.2M 1.0M 2.15
Cempra 0.1 $1.6M 340k 4.60
Cytokinetics (CYTK) 0.1 $1.5M 124k 12.10
Dicerna Pharmaceuticals 0.1 $1.6M 501k 3.17
Idera Pharmaceuticals 0.1 $1.1M 616k 1.72
Trevena 0.0 $785k 341k 2.30
Sophiris Bio 0.0 $543k 247k 2.20
Histogenics Corp Cmn 0.0 $542k 303k 1.79
Zogenix 0.0 $428k 30k 14.51
Alcobra 0.0 $306k 273k 1.12
Soleno Therapeutics 0.0 $212k 424k 0.50